The Oncologist
142 followers
142 followers
The Oncologist's posts
Post has attachment
Public
Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin‐Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and Recommendations
http://ow.ly/7UiL30dLk9k
http://ow.ly/7UiL30dLk9k
Post has attachment
Public
Post has attachment
Public
Targeted drug delays relapse of intermediate-stage lung cancer -
Post has attachment
Public
Shorter Duration of Trastuzumab May Reduce Cardiac Toxicity, Costs | ASCO Annual Meeting http://ow.ly/cIN730cmK6G
Post has attachment
Public
Post has attachment
Public
FDA granted accelerated approval to brigatinib (ALUNBRIG tablets, Takeda Pharmaceutical Company Limited, through its wholly owned subsidiary ARIAD Pharmaceuticals, Inc.) for the treatment of patients with metastatic anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib.
Post has attachment
Public
FDA expanded the indications of regorafenib - http://bit.ly/2qcq8gn
Post has attachment
Public
Post has attachment
Public
Discussions with Don S. Dizon Blog's newest blog - What’s in a Word?
Post has attachment
Public
Wait while more posts are being loaded